Clinical trials
Observational Glucose Metabolism Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2007 | 2 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 8 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Unknown status | 13 |
| Active, not recruiting | 3 |
| Not yet recruiting | 3 |
| Recruiting | 3 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ultragenyx Pharmaceutical Inc | 3 |
| Azienda Ospedaliero, Universitaria Pisana | 1 |
| CeQur Corporation | 1 |
| Central Hospital, Nancy, France | 1 |
| Centre Hospitalier Universitaire de la Guadeloupe | 1 |
| Columbia University | 1 |
| Coxa, Hospital for Joint Replacement | 1 |
| Dartmouth-Hitchcock Medical Center | 1 |
| Dasman Diabetes Institute | 1 |
| DexCom, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glucose Metabolism Disorders | 47 |
| Diabetes Mellitus | 13 |
| Metabolic Diseases | 10 |
| Endocrine System Diseases | 9 |
| Diabetes Mellitus, Type 2 | 8 |
| Diabetes Mellitus, Type 1 | 5 |
| Insulin Resistance | 5 |
| Autoimmune Diseases | 4 |
| Diabetes, Gestational | 4 |
| Prediabetic State | 4 |
Trials
Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.